Ohio · 17272

Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 1.1-2.0 Cm in Ohio

Ohio Medicare Avg
$121.15
0% below national avg
National Medicare Avg
$121.30
All states combined
Billed Charge (OH)
$372.41
What providers submit
Est. Commercial (OH)
$336.57
National avg: $357.79
Est. Cash / Self-Pay (OH)
$222.61
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

1.4K
Services in OH
291
Providers
N/A
Min Payment
N/A
Max Payment

Ohio Pricing in Context

In Ohio, CPT code 17272 (Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 1.1-2.0 Cm) carries an average Medicare payment of $121.15 — 0% below the national benchmark of $121.30. 291 providers across the state submitted claims for this procedure in 2023, performing 1.4K total services. Individual payments in OH ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Ohio is $372.41, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Ohio sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in Ohio lands near $336.57, with self-pay cash prices typically around $222.61. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 1.1-2.0 Cm cost in Ohio?

The average Medicare payment for Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 1.1-2.0 Cm in Ohio is $121.15, which is 0% below the national average of $121.30. Providers in OH typically bill $372.41 for this procedure.

What does Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 1.1-2.0 Cm cost with insurance in Ohio?

With commercial insurance in Ohio, Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 1.1-2.0 Cm costs an estimated $336.57. Without insurance, the estimated cash price is $222.61. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 1.1-2.0 Cm in Ohio?

291 providers in Ohio billed Medicare for Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 1.1-2.0 Cm in 2023, performing 1.4K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 1.1-2.0 Cm cheaper in Ohio than the national average?

Yes — Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 1.1-2.0 Cm costs 0% below the national average in Ohio. The state average Medicare payment is $121.15 compared to $121.30 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial